ARCA BIOPHARMA INC (ABIO) Stock Cash Flow
NASDAQ:ABIO - Nasdaq - US00211Y5069 - Common Stock - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -7.20M | -5.34M | -9.93M | -19.32M | -9.74M | |||
| Depreciation Amortization | 13.00K | 15.00K | 20.00K | 16.00K | 10.00K | |||
| Change In Working Capital | -292.00K | -472.00K | -1.66M | -28.00K | 1.88M | |||
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 10.00K | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 10.00K | |||
| Other non cash items | 592.00K | 782.00K | 655.00K | 572.00K | 130.00K | |||
| OPERATING CASH FLOW | -6.89M | -5.01M | -10.91M | -18.76M | -7.73M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -2.00K | -43.00K | -20.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | 0.00 | 0.00 | -2.00K | -43.00K | -20.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | -410.00K | |||
| Stock Issued/Repurchased | N/A | N/A | 0.00 | 24.07M | 50.89M | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | -977.00K | -2.03M | |||
| FINANCING CASH FLOW | 14.00K | 0.00 | 0.00 | 23.09M | 48.45M | |||
| CHANGE IN CASH | -6.87M | -5.01M | -10.91M | 4.29M | 40.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.89M | -5.01M | -10.91M | -18.76M | -7.73M | |||
| Capital Expenditure | N/A | 0.00 | -2.00K | -43.00K | -20.00K | |||
| FREE CASH FLOW | -6.89M | -5.01M | -10.91M | -18.80M | -7.75M | |||
All data in USD